Brazil secures 25,000 mpox vaccine doses

Brazil has secured 25,000 doses of mpox vaccine through a deal with the Danish vaccine maker, arranged through the Pan American Health Organization.

The shipment is expected to arrive within the next three weeks and will add to the Health Ministry’s strategic stock.

Mpox spreads mainly through close contact with infected people, including contact with skin lesions or bodily fluids.

The vaccine is not intended for the general population; Brazil’s public health system prioritizes people at higher risk of serious illness, including some people living with HIV, laboratory workers and certain close contacts.

Each person’s course is two doses 28 days apart.

By November 6, Brazil had recorded 832 cases and one death in 2026, with cases concentrated mainly in Rio de Janeiro, São Paulo, Ceará and the Federal District.

The new doses will reinforce the country’s supply, while vaccination remains targeted at priority groups.